Predictors of Ureteral Strictures after Retrograde Ureteroscopic Treatment of Impacted Ureteral Stones: A Systematic Literature Review.

impacted stone stricture ureteral perforation ureteroscopy

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
22 May 2023
Historique:
received: 03 05 2023
revised: 17 05 2023
accepted: 18 05 2023
medline: 27 5 2023
pubmed: 27 5 2023
entrez: 27 5 2023
Statut: epublish

Résumé

The stricture-formation rate following ureteroscopy ranges from 0.5 to 5% and might amount to 24% in patients with impacted ureteral stones. The pathogenesis of ureteral stricture formation is not yet fully understood. It is likely that the patient and stone characteristics, as well as intervention factors, play a role in this process. In this systematic review, we aimed to determine the potential factors responsible for ureteral stricture formation in patients having impacted ureteral stones. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) criteria, we conducted systematic online research through PubMed and Web of Science without a time restriction, applying the keywords "ureteral stone", "ureteral calculus", "impacted stone", "ureteral stenosis", "ureteroscopic lithotripsy", "impacted calculus", and "ureteral strictures" singly or in combination. After eliminating non-eligible studies, we identified five articles on ureteral stricture formation following treatment of impacted ureteral stones. Ureteral perforation and/or mucosal damage appeared as key predictors of ureteral stricture following retrograde ureteroscopy (URS) for impacted ureteral stones. Besides ureteral perforation stone size, embedded stone fragments into the ureter during lithotripsy, failed URS, degree of hydronephrosis, nephrostomy tube or double-J stent (DJS)/ureter catheter insertion were also suggested factors leading to ureteral strictures. Ureteral perforation during surgery might be considered the main risk factor for ureteral stricture formation following retrograde ureteroscopic stone removal for impacted ureteral stones.

Sections du résumé

BACKGROUND BACKGROUND
The stricture-formation rate following ureteroscopy ranges from 0.5 to 5% and might amount to 24% in patients with impacted ureteral stones. The pathogenesis of ureteral stricture formation is not yet fully understood. It is likely that the patient and stone characteristics, as well as intervention factors, play a role in this process. In this systematic review, we aimed to determine the potential factors responsible for ureteral stricture formation in patients having impacted ureteral stones.
METHODS METHODS
Following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) criteria, we conducted systematic online research through PubMed and Web of Science without a time restriction, applying the keywords "ureteral stone", "ureteral calculus", "impacted stone", "ureteral stenosis", "ureteroscopic lithotripsy", "impacted calculus", and "ureteral strictures" singly or in combination.
RESULTS RESULTS
After eliminating non-eligible studies, we identified five articles on ureteral stricture formation following treatment of impacted ureteral stones. Ureteral perforation and/or mucosal damage appeared as key predictors of ureteral stricture following retrograde ureteroscopy (URS) for impacted ureteral stones. Besides ureteral perforation stone size, embedded stone fragments into the ureter during lithotripsy, failed URS, degree of hydronephrosis, nephrostomy tube or double-J stent (DJS)/ureter catheter insertion were also suggested factors leading to ureteral strictures.
CONCLUSION CONCLUSIONS
Ureteral perforation during surgery might be considered the main risk factor for ureteral stricture formation following retrograde ureteroscopic stone removal for impacted ureteral stones.

Identifiants

pubmed: 37240709
pii: jcm12103603
doi: 10.3390/jcm12103603
pmc: PMC10218913
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

J Endourol. 2015 Aug;29(8):883-7
pubmed: 25578351
J Urol. 2001 Aug;166(2):538-40
pubmed: 11458062
Can Urol Assoc J. 2015 Nov-Dec;9(11-12):E921-4
pubmed: 26788241
Urology. 2003 Mar;61(3):518-22; discussion 522
pubmed: 12639636
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Kaohsiung J Med Sci. 2014 Mar;30(3):153-8
pubmed: 24581216
Medicina (Kaunas). 2021 Dec 16;57(12):
pubmed: 34946314
Int Urol Nephrol. 2020 May;52(5):841-849
pubmed: 31925641
Urol Int. 2012;88(3):311-5
pubmed: 22441150
World J Urol. 2015 Nov;33(11):1841-5
pubmed: 25822707
Scand J Urol. 2021 Oct;55(5):394-398
pubmed: 34355993
Kathmandu Univ Med J (KUMJ). 2020 Jan.-Mar;18(69):49-53
pubmed: 33582688
Int Braz J Urol. 2006 May-Jun;32(3):295-9
pubmed: 16813672
Cent European J Urol. 2021;74(1):57-63
pubmed: 33976917
BJU Int. 2008 Sep;102(8):1010-7
pubmed: 18485033
Br J Urol. 1994 Aug;74(2):165-9
pubmed: 7921932
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
J Endourol. 2021 Jul;35(7):985-990
pubmed: 32962439
J Endourol. 2009 Feb;23(2):243-7
pubmed: 19220083
J Urol. 1990 Feb;143(2):263-6
pubmed: 1967657
PeerJ. 2017 Jun 30;5:e3483
pubmed: 28674654
J Urol. 1998 Mar;159(3):723-6
pubmed: 9474134
J Endourol. 2018 Apr;32(4):309-314
pubmed: 29325445
Korean J Urol. 2015 Jan;56(1):63-7
pubmed: 25598938
Int Urol Nephrol. 2011 Dec;43(4):989-95
pubmed: 21479563

Auteurs

Senol Tonyali (S)

Department of Urology, Istanbul Faculty of Medicine, Istanbul University, 34452 Istanbul, Turkey.
Department of Urology, Faculty of Medicine, Medical Center, University of Freiburg, 79106 Freiburg, Germany.
European Association of Urology, Young Academic Urologist Endourology and Urolithiasis Working Party, NL-6803 Arnhem, The Netherlands.

Mehmet Yilmaz (M)

Department of Urology, Faculty of Medicine, Medical Center, University of Freiburg, 79106 Freiburg, Germany.

Lazaros Tzelves (L)

European Association of Urology, Young Academic Urologist Endourology and Urolithiasis Working Party, NL-6803 Arnhem, The Netherlands.
Department of Urology/Uro-Oncology, University College of London Hospitals (UCLH), London NW1 2BU, UK.

Esteban Emiliani (E)

European Association of Urology, Young Academic Urologist Endourology and Urolithiasis Working Party, NL-6803 Arnhem, The Netherlands.
Department of Urology, Fundacio Puigvert, Autonomous University of Barcelona, 08193 Barcelona, Spain.

Vincent De Coninck (V)

European Association of Urology, Young Academic Urologist Endourology and Urolithiasis Working Party, NL-6803 Arnhem, The Netherlands.
Department of Urology, AZ Klina, 2930 Brasschaat, Belgium.

Etienne Xavier Keller (EX)

European Association of Urology, Young Academic Urologist Endourology and Urolithiasis Working Party, NL-6803 Arnhem, The Netherlands.
Department of Urology, University Hospital Zurich, University of Zurich, 8006 Zurich, Switzerland.

Arkadiusz Miernik (A)

Department of Urology, Faculty of Medicine, Medical Center, University of Freiburg, 79106 Freiburg, Germany.

Classifications MeSH